Fairness Opinion

Duff & Phelps Provided a Fairness Opinion to the Board of Directors of Chiasma, Inc. on Its Sale to Amryt Pharma plc

Connect with us

Sheryl Cefali

Managing Director

Transaction Opinions

+1 424 249 1650

On May 4, 2021, Chiasma, Inc. (NASDAQ: CHMA), a Newton, Massachusetts-based biopharmaceutical company, signed a definitive merger agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, in an all-stock deal.

Duff & Phelps, A Kroll Business, served as a financial advisor to the board of directors of Chiasma and provided an independent fairness opinion in connection with the transaction.

About Chiasma, Inc. (NASDAQ: CHMA)
Chiasma is a commercial stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. Goodwin Procter LLP served as legal counsel to Chiasma.

About Amryt Pharma plc (NASDAQ: AMYT, AIM: AMYT)
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets. Gibson, Dunn & Crutcher LLP served as legal counsel to Amryt.

Stay Ahead with Kroll

Transaction Opinions

Our Transaction Opinions solutions span fairness opinions, solvency opinions, ESOP/ERISA advisory, board and special committee advisory and complex valuation opinions in support of liability management exercises.

Transaction Opinions

SPAC Advisory Services

Focused expertise for SPAC transactions.

SPAC Advisory Services

Private Capital Markets – Debt Advisory

Kroll has extensive experience raising capital for middle-market companies to support a wide range of transactions.

Private Capital Markets – Debt Advisory

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Mergers and Acquisitions (M&A) Advisory

Transaction Advisory Services

Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.

Transaction Advisory Services

See All Case Study

Kroll’s Transaction Advisory Services Practice Advised Esyasoft on Its Acquisition of the Entire Share Capital of Good Energy

Transaction Advisory

Kroll’s Transaction Advisory Services Practice Advised Esyasoft on Its Acquisition of the Entire Share Capital of Good Energy

Kroll’s Aerospace Defense Government Investment Banking Practice Advised Space Vector on Its Sale to Fisica

Sell Side Advisor

Kroll’s Aerospace Defense Government Investment Banking Practice Advised Space Vector on Its Sale to Fisica

Kroll’s Transaction Advisory Services Practice Advised 9fin on the Acquisition of Bond Radar

Transaction Advisory

Kroll’s Transaction Advisory Services Practice Advised 9fin on the Acquisition of Bond Radar

Kroll’s Aerospace Defense Government Investment Banking Practice Advised Blue Marble Communications on Its Sale to T2S Solutions

Financial Advisor

Kroll’s Aerospace Defense Government Investment Banking Practice Advised Blue Marble Communications on Its Sale to T2S Solutions

Explore Insights

How Fed Rate Cuts Will Impact the U.S. Economy in 2024

Enterprise Risk

How Fed Rate Cuts Will Impact the U.S. Economy in 2024

September 18, 2024

How Fed Rate Cuts will Impact the U.S. Economy

Partner with the #1 Global Fairness Opinions Provider

Fairness Opinion

Partner with the #1 Global Fairness Opinions Provider

Partner with No. 1 Global Fairness Opinions Provider

Smart Diligence: Why Better Data is Changing the Game in Consumer M&A

Transaction Advisory

Smart Diligence: Why Better Data is Changing the Game in Consumer M&A

by Paddy King

The Evolving Quality of Earnings Process in Consumer and Multi-Unit M&A

Kroll’s Insights and Implications from the FCA's Review of Private Fund Market Valuation Practices

Regulatory Updates

Kroll’s Insights and Implications from the FCA's Review of Private Fund Market Valuation Practices

by Ryan McNelley, Warren Low, Matteo Basso

Kroll’s Insights and Implications from the FCA's Review of Private Fund Market Valuation Practices

Kroll is headquartered in New York with offices around the world.

One World Trade Center

285 Fulton Street, 31st Floor

New York NY 10007

Global

© 2025 Kroll, LLC. All rights reserved. Kroll is not affiliated with Kroll Bond Rating Agency, Kroll OnTrack Inc. or their affiliated businesses. Read more.

Return to top